Portfolio of Gene Editing (CRISPR) Stocks
Here are 4 gene editing stocks that use CRISPR technology.
|4 Portfolio of Gene Editing (CRISPR) Stocks|
Stock Returns & Price Chart
Recent Prices &
|Price data from Quandl as of most recent close.|
To inspect the performance of the Portfolio of Gene Editing (CRISPR) Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.All 4 stocks are included in the portfolio computations. The current value of the portfolio assumes that $2,500.00 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.
The current value of a $10,000 investment is $13,222. The percent return is 32.22%. The annualized return is 14.99%.
|Return Summary for Portfolio of Gene Editing (CRISPR) Stocks|
|Current Value of Investment||$13,222.04|
|Number Profitable Returns||162|
|Percent Profitable Returns||54.00%|
|Number Unprofitable Returns||138|
|Percent Unprofitable Returns||46.00%|
|Profitable to Unprofitable Returns Ratio||1.17|
NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.